Contaminated albuterol leads to class action.: An article from: Trial

This digital document is an article from Trial, published by Association of Trial Lawyers of America on August 1, 1995. The length of the article is 1459 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: A class action lawsuit against Copley Pharmaceutical is drawing national attention and indicating the strengths and weaknesses of the approach. It may be the first trial of a class action suit over a nationally distributed consumer product, though the judge gave it only partial certification. The drug is intended to expand the air passages of the lungs, but a microbial contaminant in at least some batches made patients worse. The judge certified common issues, but individual ones must be tried separately.

Citation Details
Title: Contaminated albuterol leads to class action.
Author: Donald C. Dilworth
Publication:Trial (Magazine/Journal)
Date: August 1, 1995
Publisher: Association of Trial Lawyers of America
Volume: 31 Issue: n8 Page: 12(4)

Distributed by Thomson Gale